Frankfurt - Delayed Quote EUR

Ocugen, Inc. (2H51.F)

Compare
0.7720
-0.0655
(-7.82%)
At close: January 10 at 9:39:33 PM GMT+1

Research Analysis

Revenue vs. Earnings

Revenue 1.14M
Earnings -12.97M
Q4'23
Q1'24
Q2'24
Q3'24
-15M
-10M
-5M
0
 

Analyst Price Targets

Earnings Estimate

Currency in USD Current Qtr. (Dec 2024)Next Qtr. (Mar 2025)Current Year (2024)Next Year (2025)
No. of Analysts --------
Avg. Estimate 0000
Low Estimate 0000
High Estimate 0000
Year Ago EPS --------

Revenue Estimate

Currency in USD Current Qtr. (Dec 2024)Next Qtr. (Mar 2025)Current Year (2024)Next Year (2025)
No. of Analysts 4244
Avg. Estimate 300k--3.62M--
Low Estimate ----3.29M--
High Estimate 1.2M--4.6M--
Year Ago Sales 1.42M1.01M6.04M3.62M
Sales Growth (year/est) -78.86%-100.00%-40.02%-100.00%

EPS Trend

Currency in USD Current Qtr. (Dec 2024)Next Qtr. (Mar 2025)Current Year (2024)Next Year (2025)
Current Estimate 0000
7 Days Ago 0000
30 Days Ago 0000
60 Days Ago 0000
90 Days Ago 0000

EPS Revisions

Currency in USD Current Qtr. (Dec 2024)Next Qtr. (Mar 2025)Current Year (2024)Next Year (2025)
Up Last 7 Days --------
Up Last 30 Days --------
Down Last 7 Days --------
Down Last 30 Days --------

Growth Estimates

Current Qtr.Next Qtr.Current YearNext Year
2H51.F --------
S&P 500 8.59%11.42%13.98%13.43%

Upgrades & Downgrades

Maintains Chardan Capital: Buy to Buy 11/18/2024
Reiterates HC Wainwright & Co.: Buy to Buy 11/14/2024
Reiterates HC Wainwright & Co.: Buy to Buy 11/11/2024
Maintains Chardan Capital: Buy to Buy 11/9/2024
Reiterates HC Wainwright & Co.: Buy to Buy 10/23/2024
Initiated Maxim Group: Buy 10/15/2024

Related Tickers